Clinical Pharmacology Details


CINITAPRIDE


View Drug Forms

Indications & Dose:

Treatment of gastrointestinal dis¬orders associated with motility disturbances such as gastro-oesophageal reflux disease, non-ulcer dyspepsia and delayed gastric emptying.


BY MOUTH


Adults: 1 mg three times daily before meals 


Children:Not recommended.


 

Contraindications:

pregnancy

Side Effects:

Cautions:

Precautions:

It enhances the action of acotylcholme Uso with caution to elderly, patienls with a history ol dyskine-sia induced by neuroleptics Drowsiness may occur


 

Interaction:

DRUGS


Atropine: Anticholinergic agents like atropine may reduce the action of cinitapride.


Scopolamine: Anticholinergic agents like scopolamine may reduce the action of cinitapride.


Methylscopolamine: Anticholinergic agents like methylscopolamine may reduce the action of cinitapride.


Digoxin: Cinitapride can alter the absorption of digoxin as it simulates gastric emptying.


Digoxin Immune Fab: Cinitapride can alter the absorption of digoxin as it simulates gastric emptying.

Warnings:

Adverse Effects:

 Drowsiness, diarrhoea, extrapy-ramidal effects, cutaneous reactions 


 

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

Patient And Carer Advice: